Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy

2.

Taher

AT

,

Weatherall

DJ

,

Cappellini

MD

.

Thalassaemia

.

Lancet

.

2018

;

391

(

10116

):

155

-

167

.

3.

Galanello

R

,

Cao

A

.

Alpha-thalassemia

.

Genet Med

.

2011

;

13

(

2

):

83

-

88

.

4.

Hughes

JR

,

Cheng

JF

,

Ventress

N

, et al.

Annotation of cis-regulatory elements by identification, subclassification, and functional assessment of multispecies conserved sequences

.

Proc Natl Acad Sci U S A

.

2005

;

102

(

28

):

9830

-

9835

.

5.

Sollaino

MC

,

Paglietti

ME

,

Loi

D

,

Congiu

R

,

Podda

R

,

Galanello

R

.

Homozygous deletion of the major alpha-globin regulatory element (MCS-R2) responsible for a severe case of hemoglobin H disease

.

Blood

.

2010

;

116

(

12

):

2193

-

2194

.

6.

Higgs

DR

.

The molecular basis of alpha-thalassemia

.

Cold Spring Harb Perspect Med

.

2013

;

3

(

1

):

a011718

.

7.

Mettananda

S

,

Gibbons

RJ

,

Higgs

DR

.

α-Globin as a molecular target in the treatment of β-thalassemia

.

Blood

.

2015

;

125

(

24

):

3694

-

3701

.

8.

Mettananda

S

,

Gibbons

RJ

,

Higgs

DR

.

Understanding alpha-globin gene regulation and implications for the treatment of beta-thalassemia

.

Ann N Y Acad Sci

.

2016

;

1368

(

1

):

16

-

24

.

9.

Oudelaar

AM

,

Beagrie

RA

,

Kassouf

MT

,

Higgs

DR

.

The mouse alpha-globin cluster: a paradigm for studying genome regulation and organization

.

Curr Opin Genet Dev

.

2021

;

67

:

18

-

24

.

10.

Harteveld

CL

,

Higgs

DR

.

α-Thalassaemia

.

Orphanet J Rare Dis

.

2010

;

5

:

13

.

11.

Songdej

D

,

Babbs

C

,

Higgs

DR

;

Consortium, B. I

.

An international registry of survivors with Hb Bart's hydrops fetalis syndrome

.

Blood

.

2017

;

129

(

10

):

1251

-

1259

.

12.

Harewood

J

,

Azevedo

AM

. Alpha Thalassemia.

StatPearls

.

StatPearls Publishing

;

2024

.

13.

Higgs

DR

,

Weatherall

DJ

.

The alpha thalassaemias

.

Cell Mol Life Sci

.

2009

;

66

(

7

):

1154

-

1162

.

14.

King

AJ

,

Higgs

DR

.

Potential new approaches to the management of the Hb Bart's hydrops fetalis syndrome: the most severe form of alpha-thalassemia

.

Hematology Am Soc Hematol Educ Program

.

2018

;

2018

(

1

):

353

-

360

.

15.

Mettananda

S

,

Higgs

DR

.

Molecular basis and genetic modifiers of thalassemia

.

Hematol Oncol Clin North Am

.

2018

;

32

(

2

):

177

-

191

.

16.

Chiou

SS

,

Tsao

CJ

,

Tsai

SM

, et al.

Metabolic pathways related to oxidative stress in patients with hemoglobin h disease and iron overload

.

J Clin Lab Anal

.

2014

;

28

(

4

):

261

-

268

.

17.

Lee

YC

,

Yen

CT

,

Lee

YL

,

Chen

RJ

.

Thalassemia intermedia: chelator or not?

.

Int J Mol Sci

.

2022

;

23

(

17

):

10189

.

18.

Amid

A

,

Barrowman

N

,

Odame

I

,

Kirby-Allen

M

.

Optimizing transfusion therapy for survivors of haemoglobin Bart's hydrops fetalis syndrome: defining the targets for haemoglobin-H fraction and "functional" haemoglobin level

.

Br J Haematol

.

2022

;

197

(

3

):

373

-

376

.

19.

Jatavan

P

,

Chattipakorn

N

,

Tongsong

T

.

Fetal hemoglobin Bart's hydrops fetalis: pathophysiology, prenatal diagnosis and possibility of intrauterine treatment

.

J Matern Fetal Neonatal Med

.

2018

;

31

(

7

):

946

-

957

.

20.

Weatherall

D

.

The inherited disorders of haemoglobin: an increasingly neglected global health burden

.

Indian J Med Res

.

2011

;

134

(

4

):

493

-

497

.

21.

Ginzburg

Y

,

Rivella

S

.

beta-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism

.

Blood

.

2011

;

118

(

16

):

4321

-

4330

.

22.

Musallam

KM

,

Rivella

S

,

Taher

AT

.

Management of non-transfusion-dependent beta-thalassemia (NTDT): the next 5 years

.

Am J Hematol

.

2021

;

96

(

3

):

E57

-

E59

.

23.

Rivella

S

.

ß-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies

.

Haematologica

.

2015

;

100

(

4

):

418

-

430

.

24.

Giardine

BM

,

Joly

P

,

Pissard

S

, et al.

Clinically relevant updates of the HbVar database of human hemoglobin variants and thalassemia mutations

.

Nucleic Acids Res

.

2021

;

49

(

D1

):

D1192

-

D1196

.

25.

Fowkes

FJ

,

Allen

SJ

,

Allen

A

,

Alpers

MP

,

Weatherall

DJ

,

Day

KP

.

Increased microerythrocyte count in homozygous alpha(+)-thalassaemia contributes to protection against severe malarial anaemia

.

PLoS Med

.

2008

;

5

(

3

):

494

-

501.e56

.

26.

Williams

TN

,

Maitland

K

,

Bennett

S

, et al.

High incidence of malaria in alpha-thalassaemic children

.

Nature

.

1996

;

383

(

6600

):

522

-

525

.

27.

Williams

TN

,

Weatherall

DJ

,

Newbold

CI

.

The membrane characteristics of plasmodium falciparum-infected and -uninfected heterozygous alpha(0)thalassaemic erythrocytes

.

Br J Haematol

.

2002

;

118

(

2

):

663

-

670

.

28.

Goh

LPW

,

Chong

ETJ

,

Lee

PC

.

Prevalence of alpha(α)-thalassemia in Southeast Asia (2010-2020): a meta-analysis involving 83,674 subjects

.

Int J Environ Res Public Health

.

2020

;

17

(

20

):

7354

.

29.

Hockham

C

,

Ekwattanakit

S

,

Bhatt

S

, et al.

Estimating the burden of alpha-thalassaemia in Thailand using a comprehensive prevalence database for Southeast Asia

.

eLife

.

2019

;

8

:

e40580

.

30.

Fucharoen

S

,

Winichagoon

P

.

Thalassemia in SouthEast Asia: problems and strategy for prevention and control

.

Southeast Asian J Trop Med Public Health

.

1992

;

23

(

4

):

647

-

655

.

31.

Kanavakis

E

,

Tzotzos

S

,

Liapaki

A

,

Metaxotou-Mavromati

A

,

Kattamis

C

.

Frequency of alpha-thalassemia in Greece

.

Am J Hematol

.

1986

;

22

(

3

):

225

-

232

.

32.

Xu

X

,

Wu

X

.

Epidemiology and treatment of beta thalassemia major in China

.

Pediatr Investig

.

2020

;

4

(

1

):

43

-

47

.

33.

Kalle Kwaifa

I

,

Lai

MI

,

Md Noor

S

.

Non-deletional alpha thalassaemia: a review

.

Orphanet J Rare Dis

.

2020

;

15

(

1

):

166

.

34.

Lal

A

,

Locatelli

F

,

Kwiatkowski

JL

, et al.

Northstar-3: interim results from a phase 3 study evaluating lentiglobin gene therapy in patients with transfusion-dependent β-thalassemia and either a β0 or IVS-I-110 mutation at both alleles of the HBB gene [abstract]

.

Blood

.

2019

;

134

(

suppl 1

):

815

.

35.

Henderson

S

,

Chapple

M

,

Rugless

M

,

Fisher

C

,

Kinsey

S

,

Old

J

.

Haemoglobin H hydrops fetalis syndrome associated with homozygosity for the alpha2-globin gene polyadenylation signal mutation AATAAA-->AATA

.

Br J Haematol

.

2006

;

135

(

5

):

743

-

745

.

36.

Liu

S

,

Lockhart

JR

,

Fontenard

S

,

Berlett

M

,

Ryan

TM

.

Mapping the chromosomal insertion site of the GFP transgene of UBC-GFP mice to the MHC locus

.

J Immunol

.

2020

;

204

(

7

):

1982

-

1987

.

37.

Shen

FW

,

Saga

Y

,

Litman

G

, et al.

Cloning of Ly-5 cDNA

.

Proc Natl Acad Sci U S A

.

1985

;

82

(

21

):

7360

-

7363

.

38.

Breda

L

,

Ghiaccio

V

,

Tanaka

N

, et al.

Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathies

.

Mol Ther

.

2021

;

29

(

4

):

1625

-

1638

.

39.

Farashi

S

,

Harteveld

CL

.

Molecular basis of α-thalassemia

.

Blood Cells Mol Dis

.

2018

;

70

:

43

-

53

.

40.

Smetanina

NS

,

Leonova

JY

,

Levy

N

,

Huisman

TH

.

The alpha / beta and alpha 2 / alpha 1-globin mRNA ratios in different forms of alpha-thalassemia

.

Biochim Biophys Acta

.

1996

;

1315

(

3

):

188

-

192

.

41.

Smetanina

NS

,

Oner

C

,

Baysal

E

, et al.

The relative levels of alpha 2-alpha 1-and zeta-mRNA in HB H patients with different deletional and nondeletional alpha-thalassemia determinants

.

Biochim Biophys Acta

.

1996

;

1316

(

3

):

176

-

182

.

42.

Breda

L

,

Papp

TE

,

Triebwasser

MP

, et al.

In vivo hematopoietic stem cell modification by mRNA delivery

.

Science

.

2023

;

381

(

6656

):

436

-

443

.

43.

Rivella

S

,

May

C

,

Chadburn

A

,

Riviere

I

,

Sadelain

M

.

A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer

.

Blood

.

2003

;

101

(

8

):

2932

-

2939

.

44.

Shweiki

D

,

Itin

A

,

Soffer

D

,

Keshet

E

.

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

.

Nature

.

1992

;

359

(

6398

):

843

-

845

.

45.

Boning

D

,

Enciso

G

.

Hemoglobin-oxygen affinity in anemia

.

Blut

.

1987

;

54

(

6

):

361

-

368

.

46.

Abdulmalik

O

,

Darwish

NHE

,

Muralidharan-Chari

V

,

Taleb

MA

,

Mousa

SA

.

Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxia

.

Haematologica

.

2022

;

107

(

2

):

532

-

540

.

47.

Abdulmalik

O

,

Safo

MK

,

Lerner

NB

, et al.

Characterization of hemoglobin bassett (alpha94Asp-->Ala), a variant with very low oxygen affinity

.

Am J Hematol

.

2004

;

77

(

3

):

268

-

276

.

48.

Aschemeyer

S

,

Qiao

B

,

Stefanova

D

, et al.

Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin

.

Blood

.

2018

;

131

(

8

):

899

-

910

.

49.

Gardenghi

S

,

Marongiu

MF

,

Ramos

P

, et al.

Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin

.

Blood

.

2007

;

109

(

11

):

5027

-

5035

.

50.

Gardenghi

S

,

Ramos

P

,

Follenzi

A

, et al.

Hepcidin and Hfe in iron overload in β-thalassemia

.

Ann N Y Acad Sci

.

2010

;

1202(1)

:

221

-

225

.

51.

Gardenghi

S

,

Ramos

P

,

Marongiu

MF

, et al.

Hepcidin as a therapeutic tool to limit iron overload and improve anemia in beta-thalassemic mice

.

J Clin Invest

.

2010

;

120

(

12

):

4466

-

4477

.

52.

Nemeth

E

,

Tuttle

MS

,

Powelson

J

, et al.

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

.

Science

.

2004

;

306

(

5704

):

2090

-

2093

.

53.

Paszty

C

,

Mohandas

N

,

Stevens

ME

, et al.

Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue

.

Nat Genet

.

1995

;

11

(

1

):

33

-

39

.

54.

Han

XD

,

Lin

C

,

Chang

J

,

Sadelain

M

,

Kan

YW

.

Fetal gene therapy of alpha-thalassemia in a mouse model

.

Proc Natl Acad Sci U S A

.

2007

;

104

(

21

):

9007

-

9011

.

55.

Higgs

DR

,

Wood

WG

.

Long-range regulation of alpha globin gene expression during erythropoiesis

.

Curr Opin Hematol

.

2008

;

15

(

3

):

176

-

183

.

56.

Breda

L

,

Casu

C

,

Gardenghi

S

, et al.

Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients

.

PLoS One

.

2012

;

7

(

3

):

e32345

.

57.

Romero

Z

,

Campo-Fernandez

B

,

Wherley

J

, et al.

The human ankyrin 1 promoter insulator sustains gene expression in a beta-globin lentiviral vector in hematopoietic stem cells

.

Mol Ther Methods Clin Dev

.

2015

;

2

:

15012

.

58.

Burgess

DJ

.

Gene therapy: insulating from genotoxicity

.

Nat Rev Genet

.

2015

;

16

(

3

):

130

-

131

.

59.

Rivella

S

,

Sadelain

M

.

Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing

.

Semin Hematol

.

1998

;

35

(

2

):

112

-

125

.

60.

Rivella

S

,

Callegari

JA

,

May

C

,

Tan

CW

,

Sadelain

M

.

The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites

.

J Virol

.

2000

;

74

(

10

):

4679

-

4687

.

61.

Browning

DL

,

Trobridge

GD

.

Insulators to improve the safety of retroviral vectors for HIV gene therapy

.

Biomedicines

.

2016

;

4

(

1

):

4

.

62.

Zhou

X

,

Liu

Q

,

Wang

D

,

Zhang

X

,

Emery

DW

,

Li

CL

.

The cHS4 chromatin insulator reduces the rate of retroviral vector-mediated gene dysregulation associated with aberrant vector transcription

.

Cytogenet Genome Res

.

2017

;

151

(

2

):

72

-

81

.

63.

Goodman

MA

,

Arumugam

P

,

Pillis

DM

, et al.

Foamy virus vector carries a strong insulator in its long terminal repeat which reduces its genotoxic potential

.

J Virol

.

2018

;

92

(

1

):

e01639-17

.

64.

Kidd

RD

,

Russell

JE

,

Watmough

NJ

,

Baker

EN

,

Brittain

T

.

The role of beta chains in the control of the hemoglobin oxygen binding function: chimeric human/mouse proteins, structure, and function

.

Biochemistry

.

2001

;

40

(

51

):

15669

-

15675

.

65.

Curuk

MA

,

Dimovski

AJ

,

Baysal

E

, et al.

Hb Adana or alpha 2(59)(E8)Gly-->Asp beta 2, a severely unstable alpha 1-globin variant, observed in combination with the -(alpha)20.5 Kb alpha-thal-1 deletion in two Turkish patients

.

Am J Hematol

.

1993

;

44

(

4

):

270

-

275

.

66.

Baysal

E

,

Huisman

TH

.

Detection of common deletional alpha-thalassemia-2 determinants by PCR

.

Am J Hematol

.

1994

;

46

(

3

):

208

-

213

.

67.

Waye

JS

,

Eng

B

.

Allelic stability of VNTR locus 3' alpha HVR: linkage disequilibrium with the common alpha-thalassaemia-1 deletion of South-East Asia (–SEA/)

.

Hum Hered

.

1994

;

44

(

2

):

61

-

67

.

68.

Bowden

DK

,

Vickers

MA

,

Higgs

DRA

.

PCR-based strategy to detect the common severe determinants of alpha thalassaemia

.

Br J Haematol

.

1992

;

81

(

1

):

104

-

108

.

69.

Higgs

DR

,

Goodbourn

SE

,

Lamb

J

,

Clegg

JB

,

Weatherall

DJ

,

Proudfoot

NJ

.

Alpha-thalassaemia caused by a polyadenylation signal mutation

.

Nature

.

1983

;

306

(

5941

):

398

-

400

.

70.

Adekile

AD

,

Gu

LH

,

Baysal

E

, et al.

Molecular characterization of alpha-thalassemia determinants, beta-thalassemia alleles, and beta S haplotypes among Kuwaiti Arabs

.

Acta Haematol

.

1994

;

92

(

4

):

176

-

181

.

71.

Fei

YJ

,

Oner

R

,

Bözkurt

G

, et al.

Hb H disease caused by a homozygosity for the AATAAA-->AATAAG mutation in the polyadenylation site of the alpha 2-globin gene: hematological observations

.

Acta Haematol

.

1992

;

88

(

2-3

):

82

-

85

.

72.

de la Fuente-Gonzalo

F

,

Baiget

M

,

Badell

I

, et al.

Study of three families with Hb Agrinio [alpha29(B10)Leu-->Pro, CTG>CCG (alpha2)] in the Spanish population: three homozygous cases

.

Hemoglobin

.

2012

;

36

(

6

):

526

-

532

.

73.

Hall

GW

,

Thein

SL

,

Newland

AC

, et al.

A base substitution (T-->C) in codon 29 of the alpha 2-globin gene causes alpha thalassaemia

.

Br J Haematol

.

1993

;

85

(

3

):

546

-

552

.

74.

Chan

V

,

Chan

VW

,

Tang

M

,

Lau

K

,

Todd

D

,

Chan

TK

.

Molecular defects in Hb H hydrops fetalis

.

Br J Haematol

.

1997

;

96

(

2

):

224

-

228

.

75.

Altay

C

,

Say

B

,

Yetgin

S

,

Huisman

TH

.

alpha-thalassemia and beta-thalassemia in a Turkish family

.

Am J Hematol

.

1977

;

2(1)

:

1

-

15

.

76.

Berry

C

,

Hannenhalli

S

,

Leipzig

J

,

Bushman

FD

.

Selection of target sites for mobile DNA integration in the human genome

.

PLoS Comput Biol

.

2006

;

2

(

11

):

1450

-

1462.e157

.

77.

Berry

CC

,

Gillet

NA

,

Melamed

A

,

Gormley

N

,

Bangham

CRM

,

Bushman

FD

.

Estimating abundances of retroviral insertion sites from DNA fragment length data

.

Bioinformatics

.

2012

;

28

(

6

):

755

-

762

.

78.

Berry

CC

,

Nobles

C

,

Six

E

, et al.

INSPIIRED: quantification and visualization tools for analyzing integration site distributions

.

Mol Ther Methods Clin Dev

.

2017

;

4

:

17

-

26

.

79.

Schroder

AR

,

Shinn

P

,

Chen

H

,

Berry

C

,

Ecker

JR

,

Bushman

F

.

HIV-1 integration in the human genome favors active genes and local hotspots

.

Cell

.

2002

;

110

(

4

):

521

-

529

.

80.

Sherman

E

,

Nobles

C

,

Berry

CC

, et al.

INSPIIRED: a pipeline for quantitative analysis of sites of new DNA integration in cellular genomes

.

Mol Ther Methods Clin Dev

.

2017

;

4

:

39

-

49

.

81.

Amid

A

,

Chen

S

,

Brien

W

,

Kirby-Allen

M

,

Odame

I

.

Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis

.

Blood

.

2016

;

127

(

9

):

1208

-

1211

.

82.

Amid

A

,

Chen

S

,

Athale

U

, et al.

Iron overload in transfusion-dependent survivors of hemoglobin Bart's hydrops fetalis

.

Haematologica

.

2018

;

103

(

5

):

e184

-

e187

.

83.

Locatelli

F

,

Thompson

AA

,

Kwiatkowski

JL

, et al.

Betibeglogene autotemcel gene therapy for non-beta(0)/beta(0) genotype beta-thalassemia

.

N Engl J Med

.

2022

;

386

(

5

):

415

-

427

.

84.

Kanter

J

,

Thompson

AA

,

Pierciey

FJ

, et al.

Lovo-cel gene therapy for sickle cell disease: treatment process evolution and outcomes in the initial groups of the HGB-206 study

.

Am J Hematol

.

2023

;

98

(

1

):

11

-

22

.

85.

Lugthart

G

,

Verweij

EJT

,

Harteveld

CL

, et al.

Suppression of Hb Bart's to improve tissue oxygenation and fetal development in homozygous alpha-thalassemia

.

Am J Hematol

.

2024

;

99

(

8

):

1613

-

1615

.